Current Neuro-Oncology

Volume 7 Number 10
31 October 2005

Home > Publications > Current Neuro-Oncology > Volume 7, Year 2005 > Number 10, 31 October

Wemmert S, Ketter R, Rahnenführer J, Beerenwinkel N, Strowitzki M, Feiden W, Hartmann C, Lengauer T, Stockhammer F, Zang KD, Meese E, Steudel WI, von Deimling A, Urbschat S.
Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment.
Neoplasia. 2005 Oct;7(10):883-93. doi: 10.1593/neo.05307. PMID: 16242071. Observational study.

Giordana MT, D'Agostino C, Pollo B, Silvani A, Ferracini R, Paiolo A, Ghiglione P, Chiò A.
Anaplasia is rare and does not influence prognosis in adult medulloblastoma.
J Neuropathol Exp Neurol. 2005 Oct 1;64(10):869-74. doi: 10.1097/01.jnen.0000182980.64236.01. PMID: 16215458. Observational study.


Heese O, Disko A, Zirkel D, Westphal M, Lamszus K.
Neural stem cell migration toward gliomas in vitro.
Neuro Oncol. 2005 Oct 1;7(4):476-84. doi: 10.1215/S1152851704000754. PMID: 16212812. Laboratory investigation.

Hsieh PC, Chandler JP, Bhangoo S, Panagiotopoulos K, Kalapurakal JA, Marymont MH, Cozzens JW, Levy RM, Salehi S.
Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme.
Neurosurgery. 2005 Oct 1;57(4):684-92. doi: 10.1227/01.NEU.0000175550.96901.A3 PMID: 16239880. Observational study.

Leimgruber A, Ostermann S, Yeon EJ, Buff E, Maeder PP, Stupp R, Meuli RA.
Perfusion and diffusion MRI of glioblastoma progression in a four-year prospective temozolomide clinical trial.
Int J Radiat Oncol Biol Phys. 2005 Oct 13;64(3):869-75. doi: 10.1016/j.ijrobp.2005.08.015. PMID: 16226399. Interventional study.

Brandes AA.
Adding temozolomide to radiotherapy prolongs survival in people with glioblastoma.
Cancer Treat Rev. 2005 Oct 19;31(7):577-81. doi: 10.1016/j.ctrv.2005.08.004. PMID: 16242242. Interventional study. ˍ
Abstracted from: Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
N Engl J Med. 2005 Mar 10;352(10):987-96. doi: 10.1056/NEJMoa043330. PMID: 15758009. Interventional study.

Douglas JG, Stelzer KJ, Mankoff DA, Tralins KS, Krohn KA, Muzi M, Silbergeld DL, Rostomily RC, Scharnhorst J, Spence AM.
[F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure.
Int J Radiat Oncol Biol Phys. 2005 Oct 19;64(3):886-91. doi: 10.1016/j.ijrobp.2005.08.013. PMID: 16242251. Interventional study. ˍ

Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL, Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R, Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T; Children's Cancer Group.
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
J Clin Oncol. 2005 Oct 20;23(30):7621-31. doi: 10.1200/JCO.2005.09.095. PMID: 16234523. Interventional study.


McNally RJ, Eden TO, Alexander FE, Kelsey AM, Birch JM.
Is there a common aetiology for certain childhood malignancies? Results of cross-space-time clustering analyses.
Eur J Cancer. 2005 Oct 21;41(18):2911-6. doi: 10.1016/j.ejca.2005.04.051. PMID: 16243517. Observational study.